Florida has enacted legislation that allows certain stem cell treatments to proceed without FDA approval, marking a bold challenge to federal regulatory authority. The move has drawn both praise from patients seeking alternative treatments and criticism from medical regulators.
The new law permits clinics to offer autologous stem cell therapies for a range of conditions, including orthopedic injuries and certain autoimmune disorders. Supporters argue that the legislation gives patients more options, while opponents warn that unregulated treatments could pose serious health risks.
The FDA has expressed concern about states circumventing federal oversight, noting that many stem cell treatments have not been proven safe or effective through rigorous clinical trials.